NU SKIN ENTERPRISES INC - A (NUS)
US67018T1051 - Common Stock
Overall NUS gets a fundamental rating of 4 out of 10. We evaluated NUS against 36 industry peers in the Personal Care Products industry. NUS has only an average score on both its financial health and profitability. NUS is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NUS had positive earnings in the past year.
In the past year NUS had a positive cash flow from operations.
In the past 5 years NUS has always been profitable.
In the past 5 years NUS always reported a positive cash flow from operatings.
1.2 Ratios
NUS's Return On Assets of -6.52% is on the low side compared to the rest of the industry. NUS is outperformed by 71.43% of its industry peers.
NUS has a worse Return On Equity (-14.60%) than 62.86% of its industry peers.
NUS has a Return On Invested Capital of 5.34%. This is comparable to the rest of the industry: NUS outperforms 54.29% of its industry peers.
NUS had an Average Return On Invested Capital over the past 3 years of 9.55%. This is below the industry average of 13.52%.
The last Return On Invested Capital (5.34%) for NUS is well below the 3 year average (9.55%), which needs to be investigated, but indicates that NUS had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.52% | ||
| ROE | -14.6% | ||
| ROIC | 5.34% |
ROA(3y)4.65%
ROA(5y)6.71%
ROE(3y)9.62%
ROE(5y)14.02%
ROIC(3y)9.55%
ROIC(5y)11.6%
1.3 Margins
NUS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.73%, NUS perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
NUS's Operating Margin has declined in the last couple of years.
NUS has a Gross Margin of 70.70%. This is in the better half of the industry: NUS outperforms 62.86% of its industry peers.
In the last couple of years the Gross Margin of NUS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.73% | ||
| PM (TTM) | N/A | ||
| GM | 70.7% |
OM growth 3Y-29.77%
OM growth 5Y-21.55%
PM growth 3Y-61.1%
PM growth 5Y-37.43%
GM growth 3Y-2.56%
GM growth 5Y-2.02%
2. Health
2.1 Basic Checks
NUS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
NUS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NUS has less shares outstanding
NUS has a worse debt/assets ratio than last year.
2.2 Solvency
NUS has an Altman-Z score of 3.31. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
NUS has a Altman-Z score (3.31) which is in line with its industry peers.
NUS has a debt to FCF ratio of 4.78. This is a neutral value as NUS would need 4.78 years to pay back of all of its debts.
NUS has a Debt to FCF ratio (4.78) which is in line with its industry peers.
A Debt/Equity ratio of 0.53 indicates that NUS is somewhat dependend on debt financing.
The Debt to Equity ratio of NUS (0.53) is worse than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 4.78 | ||
| Altman-Z | 3.31 |
ROIC/WACC0.69
WACC7.73%
2.3 Liquidity
A Current Ratio of 1.93 indicates that NUS should not have too much problems paying its short term obligations.
NUS has a Current ratio (1.93) which is comparable to the rest of the industry.
A Quick Ratio of 1.20 indicates that NUS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.20, NUS is in line with its industry, outperforming 51.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
NUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.41%.
NUS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.77% yearly.
Looking at the last year, NUS shows a very negative growth in Revenue. The Revenue has decreased by -11.37% in the last year.
Measured over the past years, NUS shows a decrease in Revenue. The Revenue has been decreasing by -5.97% on average per year.
EPS 1Y (TTM)-64.41%
EPS 3Y-20.41%
EPS 5Y-13.77%
EPS Q2Q%-69.64%
Revenue 1Y (TTM)-11.37%
Revenue growth 3Y-8.64%
Revenue growth 5Y-5.97%
Sales Q2Q%-13.76%
3.2 Future
Based on estimates for the next years, NUS will show a decrease in Earnings Per Share. The EPS will decrease by -5.98% on average per year.
The Revenue is expected to decrease by -3.37% on average over the next years.
EPS Next Y-62.51%
EPS Next 2Y-24.7%
EPS Next 3Y-5.98%
EPS Next 5YN/A
Revenue Next Year-11.99%
Revenue Next 2Y-5.68%
Revenue Next 3Y-3.37%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
NUS is valuated reasonably with a Price/Earnings ratio of 8.96.
NUS's Price/Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 94.29% of the companies in the same industry.
NUS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 7.22, which indicates a rather cheap valuation of NUS.
NUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 97.14% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, NUS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.96 | ||
| Fwd PE | 7.22 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NUS indicates a rather cheap valuation: NUS is cheaper than 97.14% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.13 | ||
| EV/EBITDA | 3.28 |
4.3 Compensation for Growth
A cheap valuation may be justified as NUS's earnings are expected to decrease with -5.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.7%
EPS Next 3Y-5.98%
5. Dividend
5.1 Amount
NUS has a Yearly Dividend Yield of 3.66%. Purely for dividend investing, there may be better candidates out there.
NUS's Dividend Yield is rather good when compared to the industry average which is at 5.23. NUS pays more dividend than 85.71% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, NUS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.66% |
5.2 History
The dividend of NUS has a limited annual growth rate of 1.01%.
NUS has paid a dividend for at least 10 years, which is a reliable track record.
NUS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)1.01%
Div Incr Years22
Div Non Decr Years22
5.3 Sustainability
NUS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-27.29%
EPS Next 2Y-24.7%
EPS Next 3Y-5.98%
NU SKIN ENTERPRISES INC - A
NYSE:NUS (1/3/2025, 8:04:00 PM)
After market: 7.36 -0.17 (-2.26%)7.53
+0.97 (+14.79%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners87.24%
Inst Owner Change-8.4%
Ins Owners1.87%
Ins Owner Change0.25%
Market Cap374.32M
Analysts48
Price Target7.06 (-6.24%)
Short Float %3.33%
Short Ratio2.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.66% |
Dividend Growth(5Y)1.01%
DP-27.29%
Div Incr Years22
Div Non Decr Years22
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.21%
Min EPS beat(2)-13.83%
Max EPS beat(2)24.26%
EPS beat(4)3
Avg EPS beat(4)28.45%
Min EPS beat(4)-13.83%
Max EPS beat(4)74.72%
EPS beat(8)6
Avg EPS beat(8)22.35%
EPS beat(12)9
Avg EPS beat(12)13.41%
EPS beat(16)13
Avg EPS beat(16)13.94%
Revenue beat(2)1
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-3.42%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.56%
Revenue beat(8)2
Avg Revenue beat(8)-2.12%
Revenue beat(12)4
Avg Revenue beat(12)-1.89%
Revenue beat(16)5
Avg Revenue beat(16)-1.25%
PT rev (1m)-16.16%
PT rev (3m)-38.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-47.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.96 | ||
| Fwd PE | 7.22 | ||
| P/S | 0.21 | ||
| P/FCF | 4.13 | ||
| P/OCF | 2.67 | ||
| P/B | 0.53 | ||
| P/tB | 0.72 | ||
| EV/EBITDA | 3.28 |
EPS(TTM)0.84
EY11.16%
EPS(NY)1.04
Fwd EY13.86%
FCF(TTM)1.82
FCFY24.23%
OCF(TTM)2.82
OCFY37.43%
SpS35.71
BVpS14.22
TBVpS10.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.52% | ||
| ROE | -14.6% | ||
| ROCE | 6.76% | ||
| ROIC | 5.34% | ||
| ROICexc | 6.6% | ||
| ROICexgc | 8.09% | ||
| OM | 4.73% | ||
| PM (TTM) | N/A | ||
| GM | 70.7% | ||
| FCFM | 5.11% |
ROA(3y)4.65%
ROA(5y)6.71%
ROE(3y)9.62%
ROE(5y)14.02%
ROIC(3y)9.55%
ROIC(5y)11.6%
ROICexc(3y)12.41%
ROICexc(5y)15.66%
ROICexgc(3y)16.88%
ROICexgc(5y)21.6%
ROCE(3y)12.09%
ROCE(5y)14.68%
ROICexcg growth 3Y-41.38%
ROICexcg growth 5Y-32.28%
ROICexc growth 3Y-40.62%
ROICexc growth 5Y-31.15%
OM growth 3Y-29.77%
OM growth 5Y-21.55%
PM growth 3Y-61.1%
PM growth 5Y-37.43%
GM growth 3Y-2.56%
GM growth 5Y-2.02%
F-Score6
Asset Turnover1.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 4.78 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 68.61% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 89.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.31 |
F-Score6
WACC7.73%
ROIC/WACC0.69
Cap/Depr(3y)84.63%
Cap/Depr(5y)85.26%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.67%
Profit Quality(3y)265.38%
Profit Quality(5y)205.05%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.41%
EPS 3Y-20.41%
EPS 5Y-13.77%
EPS Q2Q%-69.64%
EPS Next Y-62.51%
EPS Next 2Y-24.7%
EPS Next 3Y-5.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.37%
Revenue growth 3Y-8.64%
Revenue growth 5Y-5.97%
Sales Q2Q%-13.76%
Revenue Next Year-11.99%
Revenue Next 2Y-5.68%
Revenue Next 3Y-3.37%
Revenue Next 5YN/A
EBIT growth 1Y-4.38%
EBIT growth 3Y-35.83%
EBIT growth 5Y-26.23%
EBIT Next Year13.21%
EBIT Next 3Y12.99%
EBIT Next 5YN/A
FCF growth 1Y-29.41%
FCF growth 3Y-42.43%
FCF growth 5Y-14.59%
OCF growth 1Y-27.03%
OCF growth 3Y-32.11%
OCF growth 5Y-10.16%